Company: AEMD
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001683168-25-008271
Chunk: 48

Company: AETHLON MEDICAL INC
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 8
Chunk 48
---
 was declared effective by the SEC on September 4, 2025. The combined public offering price for each share (or pre-funded
warrant in lieu thereof) and accompanying common warrant was $0.90 per unit.

The
offering closed on September 5, 2025, and we received gross proceeds of approximately $4.5 million and net proceeds of approximately $3.7
million, after deducting placement agent fees and other offering expenses. Maxim Group LLC acted as the exclusive placement agent and
received a cash fee of 6.25% of gross proceeds, reimbursement of $100,000 of expenses, and warrants to purchase up to 200,000 shares of
common stock at an exercise price of $0.90 per share.

We
intend to use the net proceeds from the offering for working capital and general corporate purposes.

In
connection with the offering, the Company and its officers and directors agreed to customary lock-up provisions restricting certain issuances
or sales of securities for up to 90 days following the closing.

Restricted Stock Unit Grants

In April 2025, the Compensation
Committee of the Board, or Compensation Committee, approved, pursuant to the terms of our Amended and Restated Non-Employee Director Compensation
Policy, or the Director Compensation Policy, the grant of the annual RSUs under the Director Compensation Policy to each of the three
non-employee directors of the Company then serving on the Board of Directors of the Company, or Board. The Director Compensation Policy
provides for a grant of stock options or $50,000 worth of RSUs at the beginning of each fiscal year for current non-employee directors
then serving on the Board, and for a grant of stock options or $75,000 worth of RSUs for a newly elected non-employee director, with each
RSU priced at the average for the closing prices for the five days preceding and including the date of grant, or $20.80 per share for
the April 2025 RSU grants. As a result, in April 2025 the four eligible directors were each granted an RSU in the amount of 1,786 shares
under the 2020 Plan. The RSUs are subject to vesting in four equal installments, with 25% of the restricted stock units vesting on
each of June 30, 2025, September 30, 2025, December 31, 2025, and March 31,